Get started
111

BIOPROTECH

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

199290 chart


Full chart

Key stats


Market capitalization
‪9.39 B‬ KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−7.96 M‬ KRW
Revenue (FY)
‪28.70 B‬ KRW
Shares float
—
Beta (1Y)
−0.60

Employees


Employees (FY)
93
Change (1Y)
+1 +1.09%
Revenue / Employee (1Y)
‪236.99 K‬ KRW
Net income / Employee (1Y)
−65.75 KRW

About BIOPROTECH


Sector
Health Technology
Industry
Medical Specialties
CEO
Ik-Ro Park
Website
protechsite.com
Headquarters
Wonju-si
Founded
2000
ISIN
KR7199290008
FIGI
BBG00FGQ3R44
Bio Protech, Inc. manufactures and supplies electromedical products and surgical apparatus. Its products include electrocardiography electrodes, electrosurgical grounding plate, oxygen sensors, low-frequency electric stimulators, and battery-operated pulse generators. The company was founded on May 19, 2000 and is headquartered in Wonju-si, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 199290 is 650 KRW — it has increased by 4.00% in the past 24 hours. Watch BIOPROTECH stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange BIOPROTECH stocks are traded under the ticker 199290.
199290 stock has risen by 28.71% compared to the previous week, the month change is a 38.30% rise, over the last year BIOPROTECH has showed a −47.15% decrease.
199290 reached its all-time high on Dec 20, 2016 with the price of 11,150 KRW, and its all-time low was 431 KRW and was reached on Oct 24, 2024. View more price dynamics on 199290 chart.
See other stocks reaching their highest and lowest prices.
199290 stock is 11.11% volatile and has beta coefficient of −0.60. Track BIOPROTECH stock price on the chart and check out the list of the most volatile stocks — is BIOPROTECH there?
Today BIOPROTECH has the market capitalization of ‪10.20 B‬, it has increased by 4.44% over the last week.
Yes, you can track BIOPROTECH financials in yearly and quarterly reports right on TradingView.
No, 199290 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 8, 2024, the company has 93.00 employees. See our rating of the largest employees — is BIOPROTECH on this list?
Like other stocks, 199290 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOPROTECH stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOPROTECH technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOPROTECH stock shows the sell signal. See more of BIOPROTECH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.